In 2023, the mortality rate for prostate malignant neoplasms in Germany was **16.1 thousand male deaths**. Forecasts suggest a consistent year-on-year increase in mortality rates: 1.35% growth from 2024 to 2025, 1.27% from 2025 to 2026, 1.26% from 2026 to 2027, and 1.24% from 2027 to 2028. The compound annual growth rate (CAGR) projected over the next five years is approximately 1.28%.

Future trends to watch for:

Advancements in medical technology and early detection methods may help slow mortality growth rates.
Changes in healthcare policies and funding could impact patient access to screening and treatment.
Demographic shifts, particularly an aging population, will likely continue to influence mortality trends.
Research into genetic factors and new treatments may offer breakthroughs that could improve survival rates.